Back
Humacyte, Inc. 10K Form
Sell
26
HUMA
Humacyte, Inc.
Last Price:
$1.30
Seasonality Move:
-22.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HUMA News And Ratings
See the #1 stock for the next 7 days that we like better than HUMA
HUMA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-24M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.03 |
| Price / Book: | 54.99 |
Profitability
| EPS (TTM): | -0.23880 |
|---|---|
| Net Income (TTM): | $-39.3M |
| Gross Margin: | $-7.2M |
| Return on Equity: | 0% |
| Return on Assets: | -30.48% |
Humacyte, Inc. Earnings Forecast
Key Humacyte, Inc. Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 2 years.
Humacyte, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | HUMA |
| Website: | humacyte.com |
Debt
| Debt-to-Equity Ratio: | -10.64 |
|---|---|
| Current Ratio: | 1.62 |
| Quick Ratio: | 0.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 12.28 |
HUMA Technical Analysis vs Fundamental Analysis
Sell
26
Humacyte, Inc. (HUMA)
is a Sell
Is Humacyte, Inc. a Buy or a Sell?
-
Humacyte, Inc. stock is rated a SellThe current Humacyte, Inc. [HUMA] share price is $1.30. The Score for HUMA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.